Tesamorelin is FDA-approved (narrowly)
These risk factors often contribute to adverse events related to pancreatic safety
This review explores gut dysbiosis across a broad spectrum of conditions, including neurodegenerative diseases (e.g., AD, PD, ALS), psychiatric disorders (e.g., MDD, BD, PTSD, anxiety), autoimmune syndromes (e.g., MS), and neuroinflammatory or toxic exposures (e.g., radiation, xenobiotics)
Studies have shown that GLP-1 agonists can trigger effects in the brain, the heart, the liver, the pancreas, the stomach, and the musclesmeaning that they could have implications for conditions other than type 2 diabetes and obesity, such as heart disease, kidney disease, liver disease, and even neurological conditions such as Alzheimer's disease